Extended-Dose Chloroquine for Malaria Treatment in Afghan Refugees
Author Information
Author(s): Howard Natasha, Durrani Naeem, Sanda Sanda, Beshir Khalid, Hallett Rachel, Rowland Mark
Primary Institution: London School of Hygiene and Tropical Medicine (LSHTM)
Hypothesis
Is a five-day treatment of chloroquine more effective than a three-day treatment for curing falciparum malaria in Afghan refugees?
Conclusion
The extended-dose chloroquine regimen can overcome some resistant infections, but its high failure rate makes it unsuitable for first-line treatment.
Supporting Evidence
- 84% of CQ25 patients experienced recrudescence compared to 51% of CQ40 patients.
- Cure rates were significantly improved with CQ40, particularly among adults.
- The study found high failure rates for CQ40 when used as second-line treatment.
Takeaway
This study tested two different lengths of malaria treatment for Afghan refugees. The longer treatment worked better, but still didn't cure enough people.
Methodology
A randomized controlled trial comparing two treatment regimens (CQ25 and CQ40) with follow-up for 60 days.
Potential Biases
Potential bias in patient selection and follow-up due to the nature of refugee health care.
Limitations
The study did not measure adherence to treatment, which could affect outcomes.
Participant Demographics
Participants were Afghan refugees with uncomplicated falciparum malaria, aged 0-15 years.
Statistical Information
P-Value
< 0.05
Confidence Interval
95%CI 0.08-0.38
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website